I think you’re making it up while you go along and that you’re not saying anything of substance. It’s all together a complex endeavor and getting the treatment approved and through the regulatory process and all of the practicalities of manufacturing and moving the inputs properly from point A to Z properly are all the critical pieces of the “drug”, which is why a “drug” like this is so much more complicated than a pharmaceutical or even well established biologics. This is a living drug that requires fresh, living inputs from the patient and operating room. It needs to be preserved and delivered properly.
Big Pharma has stayed away from cell therapies mostly because they were considered too complex, but especially when they are personalized. But that is what makes them more potent.
So saying, you live the science, not the management is a ridiculous notion. It was the management that kicked this off. The science team is in fact the set of people who put their heads together to resolve these practical details, to make it work but it still is very complicated. They are all part of a dedicated team pulling this off, together. There is no separation as you suggest. It’s purely the imagination of shorts that created that as a rhetorical way of pretending to support the company while undermining it.
Market Data 
Markets 
